BCAN's Funded Research Awards

Michael M. Shen, PhD

Professor of Urological Oncology; Associate Director of Translational Research

Institution:
Columbia University Irving Medical Center

Research:

Modeling bladder cancer metastasis using human patient‑derived tumor organoids

Summary:

Background 

Even though doctors and scientists have made progress in understanding bladder cancer, they still do not fully understand how bladder tumors grow and spread to other parts of the body, a process called metastasis. This lack of knowledge exists partly because there haven’t been good ways to study how bladder cancer invades the bladder muscle and moves to distant tissues. To help solve this problem, researchers have developed a new method using three-dimensional “organoids.” These organoids are tiny, lab-grown versions of bladder tumors made from real patient samples. They act like “mini-tumors in a dish,” closely matching the behavior of the original cancer. 

What the Study Proposes to Address 

The research team will use these organoids to better understand how bladder cancer spreads. They can change, or “edit,” certain genes within these organoids to see how specific genetic changes affect cancer’s ability to invade and travel to other areas. Once the organoids are edited, they can be placed into mouse bladders to see if and how they metastasize, or spread. The study will look at three main goals: identifying genes that help cancer spread, comparing how the original and gene-edited organoids behave in mice, and discovering whether cancer spreads through single tumor cells or groups of cells working together. 

Why This Research is Important 

This project uses an exciting new way to study bladder cancer that closely mimics how the disease behaves in people. By understanding which genes and cell behaviors drive metastasis, scientists can find new ways to stop the spread of bladder cancer. The knowledge gained from this study could lead to better treatments for patients whose cancer has advanced beyond the bladder, giving hope for more effective therapies in the future. 

 

Project Status:
Completed